Photo Cred: Anna Shvets/Pexels By Katherine Shagoury A comprehensive molecular study of the brains of people who died of the novel coronavirus (COVID-19) found clear signs of inflammation and impaired...
Read MorePhoto Cred: Mufid Majnun/Unsplash By Katherine Shagoury The Pfizer/BioNTech novel coronavirus (COVID-19) vaccination is “highly effective” against the Delta variant, Reuters reported late last week. The variant, which was first...
Read MorePhoto Cred: Braňo/Unsplash By Katherine Shagoury The novel coronavirus (COVID-19) vaccinations producer by Pfizer/BioNTech and Moderna likely produce an immune response that is strong and potentially long-lasting, according to new...
Read MorePhoto Cred: Pavel Danilyuk/Pexels By Katherine Shagoury Epstein-Barr virus (EBV) reactivation resulting from the inflammatory response to novel coronavirus (COVID-19) infection may be the cause of previously unexplained long COVID...
Read MorePhoto Cred: Fusion Medical Animation/Unsplash By Katherine Shagoury The novel coronavirus (COVID-19) variant B.1.617.2, also known as the Delta variant, could be dominant in the United States in a few...
Read MorePhoto Cred: Matt Miller/Washington University By Katherine Shagoury Novel coronavirus (COVID-19) therapies made from combinations of two antibodies are effective against a wide range of variants of the virus, according...
Read MorePhoto Cred: Kindel Media/Pexels By Katherine Shagoury SARS-CoV-2, the virus that causes the novel coronavirus (COVID-19), may have the ability to reactivate dormant tuberculosis (TB), and infection with a specific...
Read MorePhoto Cred: Bruce Mars/Unsplash By Katherine Shagoury Stress, anxiety, and depression during the first few weeks of the novel coronavirus (COVID-19) pandemic were associated with less and lower quality sleep,...
Read More